Bibliography

Found 1029 results
2019
Hoenigl M, Letendre SL, Iudicello JE, Franklin D, Porrachia M, Vargas-Meneses M, Ellis RJ, Finkelman M, Gianella S. Plasma (1→3)-β-d-glucan levels correlate with neurocognitive performance in HIV. 2019 .
Pulliam L, Sun B, Mustapic M, Chawla S, Kapogiannis D. Plasma neuronal exosomes serve as biomarkers of cognitive impairment in HIV infection and Alzheimer's disease. J Neurovirol. 2019 ;25(5):702-709.
Sun B, Fernandes N, Pulliam L. Profile of neuronal exosomes in HIV cognitive impairment exposes sex differences. AIDS. 2019 ;33(11):1683-1692.
Guha D, Lorenz DR, Misra V, Chettimada S, Morgello S, Gabuzda D. Proteomic analysis of cerebrospinal fluid extracellular vesicles reveals synaptic injury, inflammation, and stress response markers in HIV patients with cognitive impairment. J Neuroinflammation. 2019 ;16(1):254.
Gutierrez J, Byrd D, Yin MT, Morgello S. Relationship Between Brain Arterial Pathology and Neurocognitive Performance Among Individuals With Human Immunodeficiency Virus. Clin Infect Dis. 2019 ;68(3):490-497.
Umlauf A, Soontornniyomkij B, Sundermann EE, Gouaux B, Ellis RJ, Levine AJ, Moore DJ, Soontornniyomkij V. Risk of developing cerebral β-amyloid plaques with posttranslational modification among HIV-infected adults. AIDS. 2019 ;33(14):2157-2166.
Chiou B, Neely E, Kallianpur A, Connor JR. Semaphorin4A causes loss of mature oligodendrocytes and demyelination in vivo. J Neuroinflammation. 2019 ;16(1):28.
López OVélez, Gorantla S, Segarra AC, Norat MCAndino, Álvarez M, Skolasky RL, Meléndez LM. Sigma-1 Receptor Antagonist (BD1047) Decreases Cathepsin B Secretion in HIV-Infected Macrophages Exposed to Cocaine. J Neuroimmune Pharmacol. 2019 ;14(2):226-240.
Alakkas A, Ellis RJ, Watson CWei-Ming, Umlauf A, Heaton RK, Letendre S, Collier A, Marra C, Clifford DB, Gelman B, et al. White matter damage, neuroinflammation, and neuronal integrity in HAND. J Neurovirol. 2019 ;25(1):32-41.
2018
Fields JA, Spencer B, Swinton M, Qvale EMartine, Marquine MJ, Alexeeva A, Gough S, Soontornniyomkij B, Valera E, Masliah E, et al. Alterations in brain TREM2 and Amyloid-β levels are associated with neurocognitive impairment in HIV-infected persons on antiretroviral therapy. J Neurochem. 2018 .
Morgello S, Jacobs M, Murray J, Byrd D, Neibart E, Mintz L, Meloni G, Chon C, Crary J. Alzheimer's disease neuropathology may not predict functional impairment in HIV: a report of two individuals. J Neurovirol. 2018 ;24(5):629-637.
Soontornniyomkij V, Umlauf A, Soontornniyomkij B, Gouaux B, Ellis RJ, Levine AJ, Moore DJ, Letendre SL. Association of antiretroviral therapy with brain aging changes among HIV-infected adults. AIDS. 2018 ;32(14):2005-2015.
Stern AL, Ghura S, Gannon PJ, Akay-Espinoza C, Phan JM, Yee AC, Vassar R, Gelman BB, Kolson DL, Jordan-Sciutto KL. BACE1 Mediates HIV-Associated and Excitotoxic Neuronal Damage Through an APP-Dependent Mechanism. J Neurosci. 2018 ;38(18):4288-4300.
Shenoy A, Dwork A, Elkind MSV, Marshall R, Morgello S, Gutierrez J. Brain Large Artery Lymphocytic Inflammation and Human Immunodeficiency Virus-Related Brain Arterial Remodeling. J Virol. 2018 ;92(12).
Hunter MD, Shenoy A, Dwork A, Elkind MSV, Marshall R, Mohr JP, Morgello S, Gutierrez J. Brain vascular intima vulnerability among HIV-positive and negative individuals. AIDS. 2018 ;32(15):2209-2216.
Lamers SL, Fogel GB, Liu ES, Barbier AE, Rodriguez CW, Singer EJ, Nolan DJ, Rose R, McGrath MS. Brain-specific HIV Nef identified in multiple patients with neurological disease. J Neurovirol. 2018 ;24(1):1-15.
Veenstra M, Byrd D, Inglese M, Buyukturkoglu K, Williams DW, Fleysher L, Li M, Gama L, Leon-Rivera R, Calderon TM, et al. CCR2 on Peripheral Blood CD14+CD16+ Monocytes Correlates with Neuronal Damage, HIV-Associated Neurocognitive Disorders, and Peripheral HIV DNA: reseeding of CNS reservoirs?. Journal of Neuroimmune Pharmacology [Internet]. 2018 ;14. Available from: https://doi.org/10.1007/s11481-018-9792-7
Dokhale S, Shah Y, Naveen P. Combined gene expression analysis in HIV Associated Dementia, Alzheimer’s disease and Parkinson’s disease- An in-silico approach. International Journal for Computational Biology. 2018 ;7(1):52-59.
Marquine MJ, Flores I, Kamat R, Johnson N, Umlauf A, Letendre S, Jeste D, Grant I, Moore D, Heaton RK. A composite of multisystem injury and neurocognitive impairment in HIV infection: association with everyday functioning. J Neurovirol. 2018 ;24(5):549-556.
Grabyan JM, Morgan EE, Cameron MV, Villalobos J, Grant I, Woods SPaul. Deficient Emotion Processing is Associated with Everyday Functioning Capacity in HIV-associated Neurocognitive Disorder. Arch Clin Neuropsychol. 2018 ;33(2):184-193.
Marquine MJ, Heaton A, Johnson N, Rivera-Mindt M, Cherner M, Bloss C, Hulgan T, Umlauf A, Moore DJ, Fazeli P, et al. Differences in Neurocognitive Impairment Among HIV-Infected Latinos in the United States. J Int Neuropsychol Soc. 2018 ;24(2):163-175.
Buyukturkoglu K, Fleyser L, Byrd D, Morgello S, Inglese M. Diffusion Kurtosis Imaging Shows Similar Cerebral Axonal Damage in Patients with HIV Infection and Multiple Sclerosis. J Neuroimaging. 2018 ;28(3):320-327.
Clark US, Rentería MArce, Hegde RR, Morgello S. Early Life Stress-Related Elevations in Reaction Time Variability Are Associated with Brain Volume Reductions in HIV+ Adults. Front Behav Neurosci. 2018 ;12:6.
Rose R, Nolan DJ, Maidji E, Stoddart CA, Singer EJ, Lamers SL, McGrath MS. Eradication of HIV from Tissue Reservoirs: Challenges for the Cure. AIDS Res Hum Retroviruses. 2018 ;34(1):3-8.
Yang L, Niu F, Yao H, Liao K, Chen X, Kook Y, Ma R, Hu G, Buch S. Exosomal miR-9 Released from HIV Tat Stimulated Astrocytes Mediates Microglial Migration. J Neuroimmune Pharmacol. 2018 ;13(3):330-344.

Pages